Showing results (71-80 of 257) with videos related to
Sort By:
Pageof 26
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 1999
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protectionV Mijatovic, M J van der Mooren, C D Stehouwer, et al.Gynecologic Oncology|October 1, 1985
Concanavalin A-peroxidase labeling in cervical exfoliative cytopathology. I. Labeling of normal squamous cells and the detection of cancerJ H Davina, A M Stadhouders, U J van Haelst, et al.Gynecologic Oncology|October 1, 1985
Concanavalin A-peroxidase labeling in cervical exfoliative cytopathology. II. Routine assessment of labeling resultsJ H Davina, A M Stadhouders, U J van Haelst, et al.Journal of Clinical Microbiology|December 1, 1990
Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reactionA J van den Brule, C J Meijer, V Bakels, et al.Ultrastructural Pathology|January 1, 1984
Tannic acid binding of cell surfaces in normal, premalignant, and malignant squamous epithelium of the human uterine cervixJ H Davina, G E Lamers, U J van Haelst, et al.Human Reproduction (Oxford, England)|September 1, 1992
Successful treatment with methotrexate of five vital interstitial pregnanciesV H Karsdorp, F Van der Veen, R Schats, et al.Cancer Research|March 1, 1986
Feasibility of a concanavalin A-peroxidase labeling method to detect cancerous and precancerous lesions of the uterine cervixJ H Davina, A M Stadhouders, U J van Haelst, et al.Anticancer Research|May 1, 1997
Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigenJ M Bonfrer, K N Gaarenstroom, C M Korse, et al.Experimental Cell Biology|January 1, 1981
Analysis of expression of human mammary epithelial antigens in normal and malignant breast cells at the single cell level by flow cytofluorimetryJ A Peterson, J C Bartholomew, M Stampfer, et al.Cancer|July 1, 1996
CA 125: a valid marker in ovarian carcinoma patients treated with paclitaxel?E M Davelaar, J M Bonfrer, R A Verstraeten, et al.Pageof 26